Complications of TURBT
TURBT carries a 5-23% overall complication rate, with bleeding (2.8-14.1%) and bladder perforation (1.3-4.7%) being the most common, while the majority (approximately 90%) are low-grade complications (Clavien-Dindo Grade 1-2) that can be managed conservatively. 1, 2
Major Complications
Bleeding
- Most common complication, occurring in 2.8-14.1% of cases 1, 3
- Leads to repeat procedures in 84% of bleeding-related complications 3
- Blood transfusion required in approximately 3.4% of cases 3
- Strongest predictor: tumor stage, with higher-stage disease significantly increasing bleeding risk 1
Bladder Perforation
- Occurs in 1.3-4.7% of cases 1, 3
- Distribution: 83% extraperitoneal, 17% intraperitoneal 3
- Management: 89% managed conservatively, only 11% require open surgical repair 3
- Key predictors: presence of detrusor muscle in specimen and resident surgeon performing the procedure 1
- Important note: Current evidence shows minimal risk of extravesical tumor seeding with conservative management 3
Infectious Complications
- Urinary tract infections are common postoperative events 4
- Rare but severe: Septic complications including septic pulmonary embolism have been reported, particularly when bladder perforation occurs with immediate intravesical chemotherapy 5
- Sepsis incidence varies with operative time, with procedures >90 minutes showing significantly higher rates 6
Catheter-Related Complications
- Bladder spasms and catheter-related symptoms are frequent 7
- Contribute to patient discomfort but typically low-grade
High-Grade Complications (Clavien-Dindo Grade 3-5)
Occur in approximately 3.3-10% of cases 1, 2:
- Grade 3 complications: 3.3-6.4% (requiring surgical intervention)
- Grade 4 complications: 3.0% (life-threatening)
- Grade 5 (mortality): 0.1-0.6% 2
Risk Factors for Complications
Patient-Related Factors
- Age >60-75 years: significantly increases complication risk 2, 6
- ASA score 3-4: OR 2.075 for complications 4
- Nicotine use: significant predictor of high-grade complications 1
- Preoperative hospital stay ≥5 days: OR 3.76 6
- Preoperative bacteriuria or pyuria: OR 2.97 and 2.54 respectively 6
- Past pelvic radiotherapy: OR 6.00 6
- Baseline creatinine >1.4 mg/dL: associated with higher complication rates 2
Tumor-Related Factors
- Tumor size >4 cm: significantly increases complications 2, 4
- Tumor multiplicity: OR 1.878 for complications 4
- High-grade tumors: significant predictor of complications 1
- Dome location: higher complication rates 2
- pT2 stage: OR 3.188 for complications 4
- Carcinoma in situ (CIS): OR 3.476 for complications 4
Operative Factors
- Resection time >40-60 minutes: progressively increases UTI and sepsis risk 6, 2
- 30-60 min: OR 1.6 for UTI
- 60-90 min: OR 1.7 for UTI
90 min: OR 1.9 for UTI and OR 4.6 for sepsis 6
- Incomplete resection: OR 2.247 for complications and OR 1.904 for prolonged hospital stay 4
- Resident surgeon: significant predictor of bladder perforation 1, 2
Rare but Serious Complications
- Ureteral orifice injury: seldom but requires immediate treatment 7, 8
- Positional nerve damage: rare but can be severe 7
- Pancytopenia: extremely rare, associated with bladder perforation and immediate intravesical mitomycin C instillation 5
- TUR syndrome: not specifically mentioned in recent literature but remains a recognized risk
Clinical Implications
The 2026 EAU Guidelines mandate documentation of all complications in the TURBT operative record 9, emphasizing:
- Systematic performance of individual procedural steps
- Bimanual palpation before and after resection to detect perforation
- Avoidance of excessive cauterization to minimize tissue damage
- Complete documentation of extent and completeness of resection
Outpatient TURBT Considerations
Recent data shows outpatient TURBT has an 8% conversion rate to inpatient care and 11% overall complication rate 10. Predictors of outpatient failure include:
- Specimen weight ≥1 g (OR 4.35)
- Longer surgery duration
- Antiplatelet therapy 10
Impact on Subsequent Radical Cystectomy
Patients with prior maximal TURBT, especially within 1-3 months before radical cystectomy, face increased perioperative complications 11, including higher rates of Clavien-Dindo ≥3 complications (15.3% vs 7.3%), sepsis, and urinary complications.
Key Pitfalls to Avoid
- Do not routinely use antimicrobial prophylaxis beyond standard perioperative dosing, as evidence shows no significant reduction in symptomatic UTI 6
- Conservative management is appropriate for most bladder perforations; avoid unnecessary open surgical intervention 3
- Defer immediate intravesical chemotherapy if bladder perforation is suspected to avoid severe systemic complications 5
- Ensure adequate surgical experience for complex cases, as resident surgeons have higher perforation rates 1